FMA Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $2.35M | Sell |
21,766
-439
| -2% | -$47.4K | 0.88% | 39 |
|
2021
Q2 | $2.5M | Buy |
22,205
+1,337
| +6% | +$151K | 0.93% | 39 |
|
2021
Q1 | $2.26M | Buy |
20,868
+367
| +2% | +$39.7K | 0.7% | 53 |
|
2020
Q4 | $2.2M | Buy |
20,501
+4,242
| +26% | +$455K | 0.73% | 46 |
|
2020
Q3 | $1.42M | Buy |
16,259
+3,418
| +27% | +$299K | 0.57% | 60 |
|
2020
Q2 | $1.26M | Buy |
12,841
+53
| +0.4% | +$5.21K | 0.57% | 62 |
|
2020
Q1 | $974K | Buy |
12,788
+274
| +2% | +$20.9K | 0.53% | 61 |
|
2019
Q4 | $1.11M | Buy |
12,514
+913
| +8% | +$80.8K | 0.45% | 72 |
|
2019
Q3 | $878K | Buy |
11,601
+999
| +9% | +$75.6K | 0.38% | 78 |
|
2019
Q2 | $771K | Sell |
10,602
-673
| -6% | -$48.9K | 0.34% | 82 |
|
2019
Q1 | $909K | Sell |
11,275
-352
| -3% | -$28.4K | 0.42% | 75 |
|
2018
Q4 | $1.07M | Buy |
11,627
+125
| +1% | +$11.5K | 0.55% | 57 |
|
2018
Q3 | $1.09M | Buy |
11,502
+113
| +1% | +$10.7K | 0.49% | 67 |
|
2018
Q2 | $1.06M | Buy |
11,389
+36
| +0.3% | +$3.34K | 0.5% | 64 |
|
2018
Q1 | $1.08M | Sell |
11,353
-1,226
| -10% | -$116K | 0.52% | 65 |
|
2017
Q4 | $1.22M | Buy |
12,579
+1,216
| +11% | +$118K | 0.57% | 58 |
|
2017
Q3 | $1.01M | Sell |
11,363
-87
| -0.8% | -$7.73K | 0.59% | 55 |
|
2017
Q2 | $830 | Buy |
11,450
+587
| +5% | +$43 | 0.43% | 56 |
|
2017
Q1 | $708K | Buy |
+10,863
| New | +$708K | 0.36% | 78 |
|
2015
Q2 | $694K | Buy |
+10,326
| New | +$694K | 0.43% | 65 |
|
2014
Q4 | $1.45M | Sell |
22,121
-129
| -0.6% | -$8.44K | 0.5% | 82 |
|
2014
Q3 | $1.29M | Buy |
22,250
+139
| +0.6% | +$8.03K | 0.47% | 84 |
|
2014
Q2 | $1.25M | Sell |
22,111
-111
| -0.5% | -$6.27K | 0.46% | 88 |
|
2014
Q1 | $1.14M | Buy |
22,222
+919
| +4% | +$47.2K | 0.45% | 87 |
|
2013
Q4 | $1.13M | Buy |
21,303
+19
| +0.1% | +$1K | 0.46% | 86 |
|
2013
Q3 | $952K | Sell |
21,284
-248
| -1% | -$11.1K | 0.38% | 93 |
|
2013
Q2 | $890K | Buy |
+21,532
| New | +$890K | 0.38% | 93 |
|